News
Anne Wojcicki to buy back 23andMe and its data
Digest more
June 13 (Reuters) - Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron Pharmaceuticals’ REGN.O offer for the DNA-testing company ...
23andMe has said it wants to allow new bids by both parties with a deadline of 12th June, according to a Financial Times ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback